Colorado-based Colibri alleged in a 2020 lawsuit that Medtronic's Evolut devices for replacing heart valves in heart disease patients infringed a Colibri patent related to deploying artificial ...

A viable alternative to surgery On Sunday, Medtronic published five-year data from a low-risk clinical trial of its Evolut transcatheter aortic valve replacement (TAVR) system.

On Sunday, Medtronic published five-year data from a low-risk clinical trial of its Evolut transcatheter aortic valve replacement (TAVR) system. Start Your Mornings Smarter! Wake up with Breakfast ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data shows, versus surgery, the Evolut™ ...

Medtronic’s SMART Trial Shows Evolut TAVR Outperforms SAPIEN in Key Long-Term OutcomesBy submitting your details above and clicking on the 'Read Now' button, you confirm that you are happy for one of ...

These results build on additional data of Evolut BVD performance in small and large annulus patients, which will be presented as a late-breaker at CRT today, and the Evolut BVD pooled analysis by ...

Medtronic has partnered with Abbott , and will integrate its continuous glucose monitoring sensors with Medtronic’s insulin delivery systems. Limited U.S. commercial release of its Evolut FX+ ...